Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care

Gynecologic Oncology

Volumn 137, Issue 3, 2015, Pages 553-558

  Gómez Hidalgo, Natalia Rodriguez ^a   Martinez Cannon, Bertha Alejandra ^b   Nick, Alpa M ^c   Lu, Karen H ^c   Sood, Anil K ^c   Coleman, Robert L ^c   Ramirez, Pedro T ^c  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Laparoscopy; Ovarian cancer; Surgery

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN;

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; HUMAN; LAPAROSCOPIC SURGERY; LAPAROTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; OVERALL SURVIVAL; PATIENT CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; FEMALE; GYNECOLOGIC SURGERY; HEALTH CARE QUALITY; LAPAROSCOPY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; STANDARDS;

CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; STANDARD OF CARE;

EID: 84930045092     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.03.049     Document Type: Review

References (30)

1. W.J. Hoskins, W.P. McGuire, M.F. Brady, H.D. Homesley, W.T. Creasman, and M. Berman The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am. J. Obstet. Gynecol. 170 1994 974 979
2. S.C. Crawford, P.A. Vasey, J. Paul, A. Hay, J.A. Davis, and S.B. Kay Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial J. Clin. Oncol 23 2005 8802 8811
3. S.J. Chang, M. Hodeib, J. Chang, and R.E. Bristow Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis Gynecol. Oncol. 130 2013 493 498
4. N.S. Horowitz, A. Miller, B. Rungruang, S.D. Richard, N. Rodriguez, and M.A. Bookman Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182 J. Clin. Oncol. 2015 10.1200/JCO.2014.56.3106
5. D.S. Chi, E.S. Venkatraman, V. Masson, and W.J. Hoskin The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma Gynecol. Oncol. 77 2000 227 231
6. D.S. Chi, O. Zivanovic, M.J. Palayekar, E.L. Eisenhauer, N.R. Abu-Rustum, and Y. Sonoda A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma Gynecol. Oncol. 112 2009 6 10
7. S. Kang, T.-J. Kim, B.-H. Nam, S.-S. Seo, B.-G. Kim, and D.-S. Bae Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis J. Surg. Oncol. 101 2010 13 17
8. B.E. Nelson, A.T. Rosenfield, and P.E. Schwartz Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma J. Clin. Oncol. 11 1993 166 172
9. R.E. Bristow, L.R. Duska, N.C. Lambrou, E.K. Fishman, M.J. O'Neill, and E.L. Trimble A model for predicting surgical outcome in patients with advanced epithelial ovarian carcinoma using computed tomography Cancer 89 2000 1532 1540
10. S.C. Dowdy, S.A. Mullany, K.R. Brandt, B.J. Huppert, and W.A. Cliby The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma Cancer 101 2004 346 352
11. J. Hynninen, J. Kempainen, M. Lavonius, J. Virtanen, J. Matomäki, and S. Oksa A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer Gynecol. Oncol. 131 2013 389 394
12. R. Fruscio, F. Sina, C. Dolci, M. Signorelli, C. Crivellaro, and T. Dell'Anna Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer Gynecol. Oncol. 131 2013 689 693
13. R.S. Suidan, P.T. Ramirez, D.M. Sarasohn, J.B. Teitcher, S. Mironov, and R.B. Iyer A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer Gynecol. Oncol. 134 2014 455 461
14. I. Vergote, I. De Wever, W. Tjalma, M. Van Gramberen, J. Decloedt, and P. van Dam Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients Gynecol. Oncol. 71 1998 431 436
15. A. Fagotti, F. Fanfani, M. Ludovisi, R. Lo Voi, G. Bifulco, and A.C. Testa Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study Gynecol. Oncol. 96 2005 729 735
16. A. Fagotti, G. Ferrandina, F. Fanfani, A. Ercoli, D. Lorusso, and M. Rossi A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study Ann. Surg. Oncol. 13 2006 1156 1161
17. R. Angioli, P. Innocenza, A.Z. Marzio, M. Ludovico, M. Natalina, and C. Marco Diagnostic open laparoscopic in the management of advanced ovarian cancer Gynecol. Oncol. 100 2006 455 461
18. J.L. Brun, R. Rouzier, S. Uzan, and E. Darai External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score Gynecol. Oncol. 110 2008 354 359
19. A. Fagotti, G. Ferrandina, F. Fanfani, G. Garganese, F. Vizzielli, and V. Carone Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma Am. J. Obstet. Gynecol. 199 2008 642.e1 642.e6
20. A. Fagotti, G. Vizzielli, B. Constantini, A. Lecca, V. Gallota, and M.L. Gagliardi Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinomatosis in advanced ovarian cancer Acta Obstet. Gynecol. Scand. 90 2011 1126 1131
21. A. Fagotti, G. Vizzielli, P. De Iaco, D. Surico, A. Buda, and V.D. Mandato A multicentric trial (Olympia-MITO13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer Am. J. Obstet. Gynecol. 209 2013 (462.e1-11)
22. A. Fagotti, F. Fanfani, G. Vizzielli, V. Gallota, A. Ercoli, and A. Paglia Should laparoscopy be included in the work up of advanced ovarian cancer patients attempting interval debulking surgery? Gynecol. Oncol. 116 2010 72 77
23. E. Chéreau, V. Lavou, M. Ballester, C. Coutant, F. Selle, and A. Cortez External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery Anticancer Res. 12 2011 4469 4474
24. A. Fagotti, G. Vizzielli, F. Fanfani, B. Costantini, G. Ferrandina, and V. Gallotta Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience Gynecol. Oncol. 131 2013 341 346
25. G. Vizzielli, B. Costantini, L. Tortorella, M. Petrillo, F. Fanfani, and V. Chiantera Influence of intraperitoneal dissemination assessed by laparoscopy on prognosis of advanced ovarian cancer: an exploratory analysis of a single-institution experience Ann. Surg. Oncol. 21 2014 3970 3977
26. Scambia G. Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm (SCORPION). NCT0146185.
27. Scambia G, Fagotti A., Fanfani F., S. Gueli Alletti. Minimally invasive interval debulking surgery in ovarian neoplasm: a feasibility study. Protocol ID: Mission.
28. M.J. Rutten, K.N. Gaarenstroom, T. Van Gorp, H.S. van Meurs, H.J. Arts, and P.M. Bossuyt Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study BMC Cancer 12 2012 Jan 20 31 10.1186/1471-2407-12-31
29. M.J. Rutten, M.M.G. Leeflang, G.G. Kenter, B.W.J. Mol, and M. Buist Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer Cochrane Database Syst. Rev. Issue 2 2014 10.1002/14651858.CD009786.pub2 Art. No.: CD009786
30. A.M. Nick, P.T. Ramirez, and A.K. Sood A framework for personalized surgical approach to ovarian cancer Nat. Rev. Clin. Oncol. 2015 10.1038/nrclinionc.2015.26 (In Press)